Review Article | Open Access
Expression and Regulation Profile of Mature MicroRNA in the Pig: Relevance to Xenotransplantation
The pig is an important source of meat production and provides a valuable model for certain human diseases. MicroRNA (miRNA), which is noncoding RNA and regulates gene expression at the posttranscriptional level, plays a critical role in various biological processes. Studies on identification and function of mature miRNAs in multiple pig tissues are increasing, yet the literature is limited. Therefore, we reviewed current research to determine the miRNAs expressed in specific pig tissues that are involved in carcass values (including muscle and adipocytes), reproduction (including pituitary, testis, and ovary), and development of some solid organs (e.g., brain, lung, kidney, and liver). We also discuss the possible regulating mechanisms of miRNA. Finally, as pig organs are suitable candidates for xenotransplantation, biomarkers of their miRNA in xenotransplantation were evaluated.
The pig is one of the most widespread livestock species in the world, providing meat production . Although relatively expensive to breed and with a relatively long gestation period (about 114 days) , the pig is still an ideal animal model for biomedical research because of its close phylogenetic proximity and similarities with humans, such as organ size, anatomical features, physiology, and organ development, compared with the mouse . The pig has been used as a model to study various issues, such as reproduction  and the neuronal system , and is employed as a source of organs and cells in xenotransplantation .
Despite its apparent importance, knowledge about the pig is still much less than has been accumulated for the mouse and rat, such as genome organization and gene expression regulation. The latest porcine genome reference (Sscrofa 11.1) was shared in the NCBI website (https://www.ncbi.nlm.nih.gov/genome/?term=pig) by the Swine Genome Sequencing Consortium (SGSC) in 2017.
When compared with the human, the pig’s genome is of comparable size and contains a similar number of protein-coding genes . One might think that the pig should also have a similar number of microRNAs (miRNAs). However, the number of porcine miRNAs available in public databases is still limited, with only 411 mature miRNAs in the miRBase (v21) compared to human (2,588) and mouse (1,982) , partly because only part of the porcine genome is available for study . The common research strategy on miRNA may include three aims: (i) characterization of miRNAs (including identification of novel miRNAs), (ii) determination of target genes, and (iii) illumination of function of miRNAs and target genes. These strategies have been widely used to describe the miRNAome in various pig tissues, such as muscle [9–12], brain , fat , embryo , pituitary , intestine , ovary , and testes .
This review is focused on the possible functions and regulating mechanisms of miRNAs in pigs, aiming towards a better understanding of the miRNAome in various tissues. Because of many similarities in morphology and physiology between pig and human, we also evaluate biomarker values of pig miRNA in pig-to-human xenotransplantation.
2. Origins and Mechanisms of miRNAs
The miRNAs, which are typical transcripts of RNA polymerase II, are small noncoding RNAs in animals and plants . They are transcribed from genomic DNA as long hairpins (pri-miRNA) with an imperfectly paired stem of ~33 bp . The pri-miRNA is excised by Drosha to generate a pre-miRNA species in the nucleus, which is the first processing step. In the second processing step, pre-miRNA is exported from the nucleus and processed by Dicer to form the mature miRNA/miRN duplex of ~22 bp length. The miRNA is then assembled into RISC (RNA-induced silencing complexes). Generally, only one strand of the duplex is stably associated with an RISC  (Figure 1).
The miRNA acts as an adaptor for RISC to specifically recognize and regulate particular target mRNAs (Figure 1). Recognition involves Watson-Crick base pairing of the 2–8th miRNA nucleotides, which is the so-called seed region . The binding sites of miRNA to mRNAs are located in the 3′ UTR (untranslated region) and usually exist in multiple copies. Most animal miRNAs bind imperfectly with mismatches. When RISCs bind to mRNAs, they can repress initiation of translation at the stage of cap recognition or 60S recruitment [71, 72]. Alternatively, they can induce mRNA deadenylation and thereby inhibit its circularization . They can also repress translation at postinitiation stage through inducing ribosomes to drop off prematurely . They can also induce deadenylation followed by decapping to facilitate mRNA degradation [75, 76] (Figure 1).
3. miRNAs in Pig Skeletal Muscle (Table 1)
As the pig is an agriculturally important species, miRNAs that affect development and growth of economically important skeletal muscle are of interest. Several miRNAs may promote myogenesis [18, 19, 23–28] (Table 1). Several others have potential function during muscle development [20–22, 28–41]. Others are involved in the development of the longissimus dorsi and psoas major muscles [20–22, 39–41], whereas others [9, 42–45] are expressed in a stage-specific manner across muscle development periods. Among them, the miR-1, miR-133, and miR-206, which are specifically expressed in cardiac and skeletal muscle , are frequently listed as the highest expressed miRNAs in porcine muscle [9, 10, 34, 77, 78]. These multiple above-mentioned miRNAs provide insights into the regulation of muscle growth and are potential candidates for further improvement of meat quality and production using molecular approaches.
4. miRNAs in Pig Adipose Tissue (Table 2)
In addition to skeletal muscle, adipose also affects the carcass value of a pig, including meat quality grade and yield. It also plays an important role in metabolic health. miR-143 was the first miRNA reported to be involved in adipose cell biology [46–48] (Table 2). The miR-210 [14, 50] and the miR-27 family [14, 51] are involved in adipogenesis. Several are abundant in both visceral and subcutaneous adipose tissues [48–50, 52], whereas others are subcutaneous adipose tissue-specific enriched miRNAs [52–55]. Some are specifically expressed in the greater omentum [52, 56, 57]. Research into pig adipose tissue miRNAs may be beneficial in meeting the increasing demand of consumers for improved pork quality, which is a topic of worldwide concern .
5. miRNAs in Other Pig Tissues (Table 3)
Although most research has hitherto been dedicated to miRNA’s roles in meat quality, emerging research has evaluated miRNA in other solid tissues in pigs, including, but not limited to, reproduction. Many miRNAs are enriched in reproductive tissues [4, 15, 17, 37] (Table 3). Others may play a role in differentiating neurons in brain development [3, 13, 58–61]. Several are highly expressed in big solid organs [1, 37, 62–64]. The miR-200b and miR-214 are key miRNAs in tooth development [65, 66].
When a miRNA is predominant, this suggests that it could have a significant role in the tissue and that it could govern or be implicated in the major constitutive functions carried out by this tissue.
6. Biomarker Values of miRNA in Xenotransplantation
The pig has become the most suitable candidate as a source organ for xenotransplantation to overcome the growing gap between the need and availability of human donor organs . Detailed genome information and emerging gene-editing technologies increase the possibility of producing pigs specific for this purpose. The xenotransplantation of organs from gene-modified pigs is associated with longer survival and less rejection . Biopsy is the gold standard for diagnosis of conditions such as acute rejection (AR), disease recurrence, and drug toxicity . However, biopsy often relies on “subjective” measures, with some variability in results and reporting methods among pathologists, or limited diagnostic accuracy associated with sampling error . There is a critical need for biomarkers for early diagnosis, treatment response, and outcome prediction in organ transplantation, with the final goal of an individualized treatment to prevent or reverse graft injury .
The miRNAs may be ideal candidates as biomarkers of disease [82–86]. Several factors (the relatively consistent changes seen in diseases, reliable analysis methods, tissue-specific expression patterns, less complexity than mRNAs, no postprocessing modification, and amplifiable signals) contribute to making miRNAs ideal candidates, especially in the cancer diagnostic field [87–91]. Profiling miRNAs can be used as markers of organ donor quality/ischemia reperfusion injury . The strong association between miRNA expression and allograft function or acute rejection demonstrates that miRNAs may be excellent biomarkers of human allograft status [81, 93]. For example, levels of miR-142-5p, miR-155, and miR-223 can each predict acute rejection with >90% sensitivity and specificity in human renal allografts [94, 95]. Because miRNAs are stably expressed in serum, plasma, urine, saliva, and other body fluids, this makes them ideal noninvasive biomarkers  to accurately monitor graft function in xenotransplantation. There are minor differences in the nucleotide composition of miRNAs among species . Therefore, the circulating pig-specific miRNAs in human body fluids have vast potential to be biomarkers after pig-to-human xenotransplantation. Graft tissue and/or circulating miRNA profiles may be used as new biomarkers in guiding the diagnostic, therapeutic, and prognostic strategies that are associated with overimmunosuppression, organ toxicity, and graft rejection or loss.
Knowledge of human development, physiology, and pathology can be obtained from suitable animal models, especially the mouse and rat, but many of their physiological parameters (e.g., size, respiratory rate) are significantly different from those in humans . Rodent genomes also have a faster rate of evolution than the human genome . The pig is not only of significant agricultural value but is also considered a good model for biomedical research . Furthermore, pigs have been identified as the most promising source of organs for xenotransplantation to counteract the shortage of human organs for transplantation .
Many miRNAs are highly conserved among related species . Studies on miRNAs in the pig will be beneficial in understanding their key regulatory roles in humans. To obtain a better insight into the biological functions of miRNAs, it is imperative to identify all miRNAs expressed in the pig genome and their potential mRNA targets [100, 101], which is becoming easier using bioinformatic methods, with a growing number of excellent tools becoming available [8, 102]. However, the false discovery rate in predictive results remains high, and experimental validation will be needed after bioinformatic prediction. We suggest, however, that pig miRNA profiles will be used as new biomarkers in pig-to-human xenotransplantation.
|RISC:||RNA-induced silencing complexes.|
Conflicts of Interest
The authors declare no conflicts of interest.
Zongpei Song wrote the manuscript, David K. C. Cooper revised the manuscript, Zhiming Cai edited the manuscript, and Lisha Mou directed the work.
This work was supported by the National Key R&D Program of China (2017YFC1103704), China Postdoctoral Science Foundation (2016M602575), Sanming Project of Medicine in Shenzhen (SZSM201412020), Fund for High Level Medical Discipline Construction of Shenzhen (2016031638), Shenzhen Foundation of Science and Technology (JCJY20160229204849975 and GJHZ20170314171357556), and Shenzhen Foundation of Health and Family Planning Commission (SZXJ2017021).
- O. Timoneda, I. Balcells, J. I. Núñez et al., “miRNA Expression Profile Analysis in Kidney of Different Porcine Breeds,” PLoS ONE, vol. 8, no. 1, Article ID e55402, 2013.
- P. Martini, G. Sales, M. Brugiolo et al., “Tissue-specific expression and regulatory networks of pig microRNAome,” PLoS ONE, vol. 9, no. 4, Article ID e89755, 2014.
- Y. Zhou, X. Tang, Q. Song et al., “Identification and Characterization of Pig Embryo MicroRNAs by Solexa Sequencing,” Reproduction in Domestic Animals, vol. 48, no. 1, pp. 112–120, 2013.
- C. Lian, B. Sun, S. Niu et al., “A comparative profile of the microRNA transcriptome in immature and mature porcine testes using Solexa deep sequencing,” FEBS Journal, vol. 279, no. 6, pp. 964–975, 2012.
- P. M. Kragh, A. L. Nielsen, J. Li et al., “Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer's disease-causing dominant mutation APPsw,” Transgenic Research, vol. 18, no. 4, pp. 545–558, 2009.
- D. K. C. Cooper, M. B. Ezzelarab, H. Hara et al., “The pathobiology of pig-to-primate xenotransplantation: A historical review,” Xenotransplantation, vol. 23, no. 2, pp. 83–105, 2016.
- M. A. M. Groenen, A. L. Archibald, H. Uenishi, C. K. Tuggle, Y. Takeuchi, M. F. Rothschild et al., “Analyses of pig genomes provide insight into porcine demography and evolution,” Nature, vol. 491, no. 7424, pp. 393–398, 2012.
- A. Kozomara and S. Griffiths-Jones, “miRBase: annotating high confidence microRNAs using deep sequencing data,” Nucleic Acids Research, vol. 42, pp. D68–D73, 2013.
- T.-H. Huang, M.-J. Zhu, X.-Y. Li, and S.-H. Zhao, “Discovery of porcine microRNAs and profiling from skeletal muscle tissues during development,” PLoS ONE, vol. 3, no. 9, Article ID e3225, 2008.
- T. G. McDaneld, T. P. L. Smith, G. P. Harhay, and R. T. Wiedmann, “Next-generation sequencing of the porcine skeletal muscle transcriptome for computational prediction of microRNA gene targets,” PLoS ONE, vol. 7, no. 7, Article ID e42039, 2012.
- S. S. Xie, T. H. Huang, Y. Shen et al., “Identification and characterization of microRNAs from porcine skeletal muscle,” Animal Genetics, vol. 41, no. 2, pp. 179–190, 2010.
- A. Maxmen, “Model pigs face messy path,” Nature, vol. 486, no. 7404, p. 453, 2012.
- A. Podolska, B. Kaczkowski, P. K. Busk et al., “Microrna expression profiling of the porcine developing,” PLoS ONE, vol. 6, no. 1, Article ID e14494, 2011.
- Y. Guo, D. Mo, Y. Zhang et al., “MicroRNAome Comparison between Intramuscular and Subcutaneous Vascular Stem Cell Adipogenesis,” PLoS ONE, vol. 7, no. 9, Article ID e45410, 2012.
- H. Li, Q. Xi, Y. Xiong et al., “A comprehensive expression profile of microRNAs in porcine pituitary,” PLoS ONE, vol. 6, no. 9, Article ID e24883, 2011.
- S. Sharbati, M. R. Friedländer, J. Sharbati et al., “Deciphering the porcine intestinal microRNA transcriptome,” BMC Genomics, vol. 11, no. 1, article 275, 2010.
- M. Li, Y. Liu, T. Wang et al., “Repertoire of porcine microRNAs in adult ovary and testis by deep sequencing,” International Journal of Biological Sciences, vol. 7, no. 7, pp. 1045–1055, 2011.
- N. Liu, A. H. Williams, Y. Kim et al., “An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 104, no. 52, pp. 20844–20849, 2007.
- J. F. Chen, E. M. Mandel, J. M. Thomson et al., “The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation,” Nature Genetics, vol. 38, no. 2, pp. 228–233, 2006.
- Y. Liu, M. Li, J. Ma et al., “Identification of differences in microRNA transcriptomes between porcine oxidative and glycolytic skeletal muscles,” BMC Molecular Biology, vol. 14, article no. 7, 2013.
- Z. Niu, A. Li, S. X. Zhang, and R. J. Schwartz, “Serum response factor micromanaging cardiogenesis,” Current Opinion in Cell Biology, vol. 19, no. 6, pp. 618–627, 2007.
- P. L. Boutz, G. Chawla, P. Stoilov, and D. L. Black, “MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development,” Genes & Development, vol. 21, no. 1, pp. 71–84, 2007.
- E. Lozano-Velasco, A. Contreras, C. Crist, F. Hernández-Torres, D. Franco, and A. E. Aránega, “Pitx2c modulates Pax3+/Pax7+ cell populations and regulates Pax3 expression by repressing miR27 expression during myogenesis,” Developmental Biology, vol. 357, no. 1, pp. 165–178, 2011.
- D. L. Allen and A. S. Loh, “Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle,” American Journal of Physiology-Cell Physiology, vol. 300, no. 1, pp. C124–C137, 2011.
- L. Qin, Y. Chen, X. Liu et al., “Integrative analysis of porcine micrornaome during skeletal muscle development,” PLoS ONE, vol. 8, no. 9, p. e72418, 2013.
- J. Zhang, Z. Ying, Z. Tang, L. Long, and K. Li, “MicroRNA-148a promotes myogenic differentiation by targeting the ROCK1 gene,” The Journal of Biological Chemistry, vol. 287, no. 25, pp. 21093–21101, 2012.
- L. Chen, P. Wu, X.-H. Guo et al., “miR-143: A novel regulator of myod expression in fast and slow muscles of Siniperca chuatsi,” Current Molecular Medicine, vol. 14, no. 3, pp. 370–375, 2014.
- J. Zuo, F. Wu, Y. Liu et al., “MicroRNA transcriptome profile analysis in porcine muscle and the effect of miR-143 on the MYH7 gene and protein,” PLoS ONE, vol. 10, no. 4, Article ID e0124873, 2015.
- J. Gagan, B. K. Dey, R. Layer, Z. Yan, and A. Dutta, “MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation,” The Journal of Biological Chemistry, vol. 286, no. 22, pp. 19431–19438, 2011.
- X. Hou, Z. Tang, H. Liu, N. Wang, H. Ju, and K. Li, “Discovery of MicroRNAs associated with myogenesis by deep sequencing of serial developmental skeletal muscles in pigs,” PLoS ONE, vol. 7, no. 12, Article ID e52123, 2012.
- N. Motohashi, M. S. Alexander, J. C. Casar, and L. M. Kunkel, “Identification of a novel microRNA that regulates the proliferation and differentiation in muscle side population cells,” Stem Cells and Development, vol. 21, no. 16, pp. 3031–3043, 2012.
- H. S. Ryu, S.-Y. Park, D. Ma, J. Zhang, and W. Lee, “The induction of microrna targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes,” PLoS ONE, vol. 6, no. 3, Article ID e17343, 2011.
- S. Wang, A. B. Aurora, B. A. Johnson et al., “The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis,” Developmental Cell, vol. 15, no. 2, pp. 261–271, 2008.
- M. Nielsen, J. H. Hansen, J. Hedegaard et al., “MicroRNA identity and abundance in porcine skeletal muscles determined by deep sequencing,” Animal Genetics, vol. 41, no. 2, pp. 159–168, 2010.
- E. Davis, F. Caiment, X. Tordoir et al., “RNAi-mediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus,” Current Biology, vol. 15, no. 8, pp. 743–749, 2005.
- T. Li, R. Wu, Y. Zhang, and D. Zhu, “A systematic analysis of the skeletal muscle miRNA transcriptome of chicken varieties with divergent skeletal muscle growth identifies novel miRNAs and differentially expressed miRNAs,” BMC Genomics, vol. 12, article 186, 2011.
- M. Li, Y. Xia, Y. Gu et al., “MicroRNAome of porcine pre- and postnatal development,” PLoS ONE, vol. 5, no. 7, Article ID e11541, 2010.
- S. Roush and F. J. Slack, “The let-7 family of microRNAs,” Trends in Cell Biology, vol. 18, no. 10, pp. 505–516, 2008.
- D. J. Mahoney, G. Parise, S. Melov, A. Safdar, and M. A. Tarnopolsky, “Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise,” The FASEB Journal, vol. 19, no. 11, pp. 1498–1500, 2005.
- C. Handschin and B. M. Spiegelman, “The role of exercise and PGC1α in inflammation and chronic disease,” Nature, vol. 454, no. 7203, pp. 463–469, 2008.
- A. Safdar, A. Abadi, M. Akhtar, B. P. Hettinga, and M. A. Tarnopolsky, “miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57Bl/6J male mice,” PLoS ONE, vol. 4, no. 5, Article ID e5610, 2009.
- I. Naguibneva, M. Ameyar-Zazoua, A. Polesskaya et al., “The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation,” Nature Cell Biology, vol. 8, no. 3, pp. 278–284, 2006.
- W. H. D. Townley-Tilson, T. E. Callis, and D. Wang, “MicroRNAs 1, 133, and 206: Critical factors of skeletal and cardiac muscle development, function, and disease,” The International Journal of Biochemistry & Cell Biology, vol. 42, no. 8, pp. 1252–1255, 2010.
- K. Yuasa, Y. Hagiwara, M. Ando, A. Nakamura, S. Takeda, and T. Hijikata, “MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy,” Cell Structure and Function, vol. 33, no. 2, pp. 163–169, 2008.
- C. Anderson, H. Catoe, and R. Werner, “MIR-206 regulates connexin43 expression during skeletal muscle development,” Nucleic Acids Research, vol. 34, no. 20, pp. 5863–5871, 2006.
- C. Esau, X. Kang, E. Peralta et al., “MicroRNA-143 regulates adipocyte differentiation,” The Journal of Biological Chemistry, vol. 279, no. 50, pp. 52361–52365, 2004.
- K. R. Cordes, N. T. Sheehy, M. P. White et al., “MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity,” Nature, vol. 460, no. 7256, pp. 705–710, 2009.
- G. Li, Y. Li, X. Li, X. Ning, M. Li, and G. Yang, “MicroRNA identity and abundance in developing swine adipose tissue as determined by solexa sequencing,” Journal of Cellular Biochemistry, vol. 112, no. 5, pp. 1318–1328, 2011.
- R. Alexander, H. Lodish, and L. Sun, “MicroRNAs in adipogenesis and as therapeutic targets for obesity,” Expert Opinion on Therapeutic Targets, vol. 15, no. 5, pp. 623–636, 2011.
- L. Qin, Y. Chen, Y. Niu et al., “A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/β-catenin signaling pathway,” BMC Genomics, vol. 11, article 320, 2010.
- M. Karbiener, C. Fischer, S. Nowitsch et al., “microRNA miR-27b impairs human adipocyte differentiation and targets PPARγ,” Biochemical and Biophysical Research Communications, vol. 390, no. 2, pp. 247–251, 2009.
- J. Ma, Z. Jiang, S. He et al., “Intrinsic features in MicroRNA transcriptomes link porcine visceral rather than subcutaneous adipose tissues to metabolic risk,” PLoS ONE, vol. 8, no. 11, Article ID e80041, 2013.
- S. Liu, Y. Yang, and J. Wu, “TNFα-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors,” Biochemical and Biophysical Research Communications, vol. 414, no. 3, pp. 618–624, 2011.
- L. Sun, H. Xie, M. A. Mori et al., “Mir193b-365 is essential for brown fat differentiation,” Nature Cell Biology, vol. 13, no. 8, pp. 958–965, 2011.
- S. Pan, Y. Zheng, R. Zhao, and X. Yang, “MicroRNA-130b and microRNA-374b mediate the effect of maternal dietary protein on offspring lipid metabolism in Meishan pigs,” British Journal of Nutrition, vol. 109, no. 10, pp. 1731–1738, 2013.
- C. Xiao, L. Srinivasan, D. P. Calado et al., “Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes,” Nature Immunology, vol. 9, no. 4, pp. 405–414, 2008.
- A. Ventura, A. G. Young, M. M. Winslow et al., “Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA cluster,” Cell, vol. 132, no. 5, pp. 875–886, 2008.
- N. Uchida, “MicroRNA-9 Controls a Migratory Mechanism in Human Neural Progenitor Cells,” Cell Stem Cell, vol. 6, no. 4, pp. 294–296, 2010.
- S. S. Hébert, K. Horré, L. Nicolaï et al., “MicroRNA regulation of Alzheimer's Amyloid precursor protein expression,” Neurobiology of Disease, vol. 33, no. 3, pp. 422–428, 2009.
- S.-Y. Park, J. H. Lee, M. Ha, J.-W. Nam, and V. N. Kim, “miR-29 miRNAs activate p53 by targeting p85α and CDC42,” Nature Structural & Molecular Biology, vol. 16, no. 1, pp. 23–29, 2009.
- I. Koturbash, F. Zemp, B. Kolb, and O. Kovalchuk, “Sex-specific radiation-induced microRNAome responses in the hippocampus, cerebellum and frontal cortex in a mouse model,” Mutation Research - Genetic Toxicology and Environmental Mutagenesis, vol. 722, no. 2, pp. 114–118, 2011.
- S.-S. Xie, X.-Y. Li, T. Liu, J.-H. Cao, Q. Zhong, and S.-H. Zhao, “Discovery of porcine microRNAs in multiple tissues by a solexa deep sequencing approach,” PLoS ONE, vol. 6, no. 1, Article ID e16235, 2011.
- D. Gatfield, G. Le Martelot, C. E. Vejnar et al., “Integration of microRNA miR-122 in hepatic circadian gene expression,” Genes & Development, vol. 23, no. 11, pp. 1313–1326, 2009.
- C. Esau, S. Davis, S. F. Murray et al., “miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting,” Cell Metabolism, vol. 3, no. 2, pp. 87–98, 2006.
- A. Li, T. Song, F. Wang et al., “MicroRNAome and Expression Profile of Developing Tooth Germ in Miniature Pigs,” PLoS ONE, vol. 7, no. 12, Article ID e52256, 2012.
- A. Sehic, S. Risnes, C. Khuu, Q.-E. Khan, and H. Osmundsen, “Effects of in vivo transfection with anti-miR-214 on gene expression in murine molar tooth germ,” Physiological Genomics, vol. 43, no. 9, pp. 488–498, 2011.
- V. N. Kim, “MicroRNA biogenesis: coordinated cropping and dicing,” Nature Reviews Molecular Cell Biology, vol. 6, no. 5, pp. 376–385, 2005.
- D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004.
- V. N. Kim, J. Han, and M. C. Siomi, “Biogenesis of small RNAs in animals,” Nature Reviews Molecular Cell Biology, vol. 10, no. 2, pp. 126–139, 2009.
- R. S. Pillai, C. G. Artus, and W. Filipowicz, “Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis,” RNA, vol. 10, no. 10, pp. 1518–1525, 2004.
- X. C. Ding and H. Großhans, “Repression of C. elegans microRNA targets at the initiation level of translation requires GW182 proteins,” EMBO Journal, vol. 28, no. 3, pp. 213–222, 2009.
- M. Wakiyama, K. Takimoto, O. Ohara, and S. Yokoyama, “Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system,” Genes & Development, vol. 21, no. 15, pp. 1857–1862, 2007.
- I. Behm-Ansmant, J. Rehwinkel, T. Doerks, A. Stark, P. Bork, and E. Izaurralde, “Izaurralde E. mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes,” Genes & Development, vol. 20, no. 14, pp. 1885–1898, 2006.
- S. Nottrott, M. J. Simard, and J. D. Richter, “Human let-7a miRNA blocks protein production on actively translating polyribosomes,” Nature Structural & Molecular Biology, vol. 13, no. 12, pp. 1108–1114, 2006.
- R. W. Carthew and E. J. Sontheimer, “Origins and mechanisms of miRNAs and siRNAs,” Cell, vol. 136, no. 4, pp. 642–655, 2009.
- A. J. Giraldez, Y. Mishima, J. Rihel et al., “Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs,” Science, vol. 312, no. 5770, pp. 75–79, 2006.
- T. G. McDaneld, T. P. L. Smith, M. E. Doumit et al., “MicroRNA transcriptome profiles during swine skeletal muscle development,” BMC Genomics, vol. 10, article 77, 2009.
- J. Brennecke, A. Stark, and S. M. Cohen, “Not miR-ly muscular: MicroRNAs and muscle development,” Genes & Development, vol. 19, no. 19, pp. 2261–2264, 2005.
- W. W. Williams, D. Taheri, N. Tolkoff-Rubin, and R. B. Colvin, “Clinical role of the renal transplant biopsy,” Nature Reviews Nephrology, vol. 8, no. 2, pp. 110–121, 2012.
- N. Kozakowski and H. Regele, “Biopsy diagnostics in renal allograft rejection: from histomorphology to biological function,” Transplant International, vol. 22, no. 10, pp. 945–953, 2009.
- V. R. Mas, C. I. Dumur, M. J. Scian, R. C. Gehrau, and D. G. Maluf, “MicroRNAs as biomarkers in solid organ transplantation,” American Journal of Transplantation, vol. 13, no. 1, pp. 11–19, 2013.
- DG. Maluf, CI. Dumur, and JL. Suh, “The urine microRNA profile may help monitor post-transplant renal graft function,” Kidney International, vol. 85, no. 2, pp. 439–449, 2014.
- K. Bhatt, Q. S. Mi, and Z. Dong, “MicroRNAs in kidneys: biogenesis, regulation, and pathophysiological roles,” American Journal of Physiology-Renal Physiology, vol. 300, no. 3, pp. F602–F610, 2011.
- X. Chen, Y. Ba, L. Ma et al., “Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases,” Cell Research, vol. 18, no. 10, pp. 997–1006, 2008.
- J. G. Godwin, X. Ge, K. Stephan, A. Jurisch, S. G. Tullius, and J. Iacomini, “Identification of a microRNA signature of renal ischemia reperfusion injury,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 107, no. 32, pp. 14339–14344, 2010.
- M. A. Kanak, M. Takita, R. Shahbazov et al., “Evaluation of MicroRNA375 as a novel biomarker for graft damage in clinical islet transplantation,” Transplantation, vol. 99, no. 8, pp. 1568–1573, 2015.
- J. P. S. Chawla, N. Iyer, K. S. Soodan, A. Sharma, S. K. Khurana, and P. Priyadarshni, “Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer,” Oral Oncology, vol. 51, no. 8, pp. 731–737, 2015.
- L. Sun, Y. Chen, Q. Su et al., “Increased plasma miRNA-30a as a biomarker for non-small cell lung cancer,” Medical Science Monitor: International Medical Journal of Experimental & Clinical Research, vol. 22, pp. 647–655, 2016.
- J. Wang, H. Ye, D. Zhang et al., “MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer,” Cancer Cell International, vol. 16, no. 1, article 12, 2016.
- S. Guo, W. Guo, S. Li et al., “633 Serum miR-16: A potential biomarker for predicting melanoma prognosis,” Journal of Investigative Dermatology, vol. 136, 1, no. 5, p. S112, 2016.
- Widodo, M. S. Djati, and M. Rifa'i, “Role of MicroRNAs in carcinogenesis that potential for biomarker of endometrial cancer,” Annals of Medicine and Surgery, vol. 7, pp. 9–13, 2016.
- M. D. Shapiro, J. Bagley, J. Latz et al., “Microrna expression data reveals a signature of kidney damage following Ischemia reperfusion injury,” PLoS ONE, vol. 6, no. 8, Article ID e23011, 2011.
- J. Shan, L. Feng, L. Luo et al., “MicroRNAs: Potential biomarker in organ transplantation,” Transplant Immunology, vol. 24, no. 4, pp. 210–215, 2011.
- D. Anglicheau, V. K. Sharma, R. Ding et al., “MicroRNA expression profiles predictive of human renal allograft status,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 106, no. 13, pp. 5330–5335, 2009.
- J. Tao, X. Yang, Z. Han et al., “Serum MicroRNA-99a helps detect acute rejection in renal transplantation,” Transplantation Proceedings, vol. 47, no. 6, pp. 1683–1687, 2015.
- C. I. Wu and W. H. Li, “Evidence for higher rates of nucleotide substitution in rodents than in man,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 6, pp. 1741–1745, 1985.
- D. Rocha and G. Plastow, “Commercial pigs: an untapped resource for human obesity research?” Drug Discovery Therapy, vol. 11, no. 11-12, pp. 475–477, 2006.
- D. K. C. Cooper, B. Gollackner, and D. H. Sachs, “Will the pig solve the transplantation backlog?” Annual Review of Medicine, vol. 53, pp. 133–147, 2002.
- A. K. L. Leung and P. A. Sharp, “microRNAs: A Safeguard against Turmoil?” Cell, vol. 130, no. 4, pp. 581–585, 2007.
- P. Martini, G. Sales, E. Calura et al., “Systems biology approach to the dissection of the complexity of regulatory networks in the S. scrofa cardiocirculatory system,” International Journal of Molecular Sciences, vol. 14, no. 11, pp. 23160–23187, 2013.
- C. Chen, H. Ai, J. Ren et al., “A global view of porcine transcriptome in three tissues from a full-sib pair with extreme phenotypes in growth and fat deposition by paired-end RNA sequencing,” BMC Genomics, vol. 12, article no. 448, 2011.
- W. Zhao, W. Liu, D. Tian et al., “wapRNA: A web-based application for the processing of RNA sequences,” Bioinformatics, vol. 27, no. 21, Article ID btr504, pp. 3076-3077, 2011.
Copyright © 2018 Zongpei Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.